1. Home
  2. CYTK vs ALV Comparison

CYTK vs ALV Comparison

Compare CYTK & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$56.27

Market Cap

7.8B

Sector

Health Care

ML Signal

N/A

Logo Autoliv Inc.

ALV

Autoliv Inc.

N/A

Current Price

$120.48

Market Cap

8.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
ALV
Founded
1997
1953
Country
United States
Sweden
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.4B
IPO Year
2004
1997

Fundamental Metrics

Financial Performance
Metric
CYTK
ALV
Price
$56.27
$120.48
Analyst Decision
Buy
Buy
Analyst Count
22
18
Target Price
$109.42
★ $131.25
AVG Volume (30 Days)
★ 1.9M
869.3K
Earning Date
11-04-2026
10-23-2026
Dividend Yield
N/A
★ 3.37%
EPS Growth
N/A
★ 18.78
EPS
N/A
★ 5.36
Revenue
$13,368,000.00
★ $10,815,000,000.00
Revenue This Year
$87.17
$2.43
Revenue Next Year
$170.90
$2.15
P/E Ratio
★ N/A
$22.19
Revenue Growth
N/A
★ 4.09
52 Week Low
$53.58
$99.16
52 Week High
$88.31
$132.17

Technical Indicators

Market Signals
Indicator
CYTK
ALV
Relative Strength Index (RSI) 38.80 52.97
Support Level N/A $119.84
Resistance Level $66.62 $126.20
Average True Range (ATR) 2.69 2.88
MACD -0.24 -0.01
Stochastic Oscillator 24.29 45.18

Price Performance

Historical Comparison
CYTK
ALV

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ALV Autoliv Inc.

Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.

Share on Social Networks: